IP Library Granted Patent US 8,048,376
Granted Patent B2
US 8,048,376 · App. 12/953,664 · Granted Nov 1, 2011

Particle agglutination in a tip

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,048,376
App. No.
12/953,664
Granted
Nov 1, 2011
Kind
B2
Abstract

An apparatus and a related method for performing particle agglutination reactions in at least one disposable probe tip are disclosed. The at least one probe tip includes a sample cavity for sample acquisition, at least one flanking cavity for the capture of particles by centrifugation or other means, a transition zone for the mixing of the sample with reagents for agglutination and a detection zone for the optical detection of particle agglutination. A mechanism may be attached to the probe tip for the controlled movement of fluids through the internal volume of the probe tip. The probe tip is particularly useful for the automation of high-throughput agglutination-type assays.

Claims (34)

1. A method of performing an agglutination reaction in a probe tip, said method comprising the steps of:

a) providing a probe tip comprising:

i. a first port configured to permit negative or positive pressure to an internal volume of a probe tip;

ii. a sample cavity of said internal volume in fluid communication with said port;

iii. at least one flanking cavity of said internal volume configured to capture particles in the sample after separation of the particles from the remainder of the sample, wherein said flanking cavity is in fluid communication with said sample cavity;

iv. a detection cavity of said internal volume configured for the detection of agglutination within the sample, wherein said detection cavity is in fluid connection with said sample cavity;

v. a transition zone of said internal volume between said sample cavity and said detection cavity, configured for rotational mixing of the sample moving back and forth through said transition zone; and

vi. a second port in fluid connection with said detection cavity, said second port configured to permit reagents to be aspirated into or dispensed from said internal volume of said probe tip;

b) aspirating a sample into said sample cavity of said probe tip;

c) separating the particles from the remainder of the sample and capturing the particles in said at least one flanking cavity of said probe tip;

d) dispensing the sample supernatant from said probe tip;

e) aspirating reagents for agglutination into said probe tip;

f) resuspending the sample pellet from said at least one flanking cavity; and

g) moving the resuspended sample pellet to said detection cavity, wherein agglutination in the resuspended sample pellet is detected in said detection cavity.

2. The method of claim 1 , wherein the sample pellet is resuspended by rotational mixing at said transition zone of said probe tip.

3. The method of claim 1 , wherein the sample comprises a cell suspension.

4. The method of claim 1 , wherein the cell suspension comprises red blood cells.

5. The method of claim 3 , wherein the cell suspension comprises a patient's whole blood.

6. The method of claim 3 , wherein the cell suspension comprises a patient's serum and a donor's red blood cells.

7. The method of claim 1 , wherein the reagents for agglutination comprise a ligand-binding molecule.

8. The method of claim 7 , wherein the ligand-binding molecule is an antibody.

9. The method of claim 1 , wherein the reagents for agglutination comprise Coomb's reagent.

10. The method of claim 1 , wherein the reagents for agglutination comprise microspheres.

11. The method of claim 1 , wherein the reagents for agglutination comprise microspheres bound to ligand-binding molecules.

12. The method of claim 1 , wherein the reagents for agglutination comprise red blood cells of known blood group.

13. The method of claim 1 , wherein the particles are separated from the remainder of the sample by centrifugation or by separation in a magnetic field.

14. An apparatus for the detection of agglutination reactions within at least one probe tip in accordance with the method of claim 1 , said apparatus comprising:

at least one tip holder configured for the placement of said at least one said probe tip; and

a means for separating the particles in the sample from the remainder of the sample in said at least one said probe tip.

15. The apparatus of claim 14 , including a plurality of holders for retaining a plurality of said probe tips.

16. The apparatus of claim 14 , wherein said means for separating the particles comprises a centrifuge.

17. The apparatus of claim 14 , wherein said means for separating the particles comprises means for vertically agitating said at least one tip holder.

18. The apparatus of claim 14 , wherein said means for separating the particles comprises means for moving said particles in a magnetic field.

19. The apparatus of claim 17 , wherein said means for agitating includes at least one piston configured for reciprocating movement within a displacement cavity of the internal volume of said at least one probe tip to produce force to move said sample and reagents through said transition zone.

Assignments (6)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2010
From: DING, ZHONG; WILSON-COLLEY, AMY M.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 025419/0318 →